Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 14,322 shares at $34.88 ($500K) on 2017-08-09, disclosed to the SEC on 2017-08-11.
Scheduled sale ($500k) by EVP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-07-21 | $1.1M | — | Filing → |